Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) fired its board chairman, saw three directors leave in protest, and announced the resignation of the company’s CFO all at the same time that it reported quarterly earnings…
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the biggest public merger rumors out there. At least that is the belief of Wall Street. Canaccord…
How many DJIA components can raise their dividend in one week? Johnson & Johnson (NYSE: JNJ) answered that question as “Who knows, but we can make it one more!” J&J has joined the parade…
The annual report of the Trustees of the Social Security and Medicare trust funds has been released, and no matter what one believes about how the US should provide a safety net for its…
Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to acquire the company. With another small-cap to mid-cap biotech and emerging pharma company being gobbled…
Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer. In February Amylin turned down a $3.5 billion ($22/share) offer from Bristol-Meyers Squibb Co.…
The total number of cosmetic procedures performed in the United States by plastic surgeons has nearly doubled since 2000. Surgeries are on the decline, but minimally invasive procedures — such as Botox injections and…
Health care benefits manager SXC Health Solutions Corp. (NASDAQ: SXCI) has agreed to acquire competitor Catalyst Health Solutions Inc. (NASDAQ: CHSI) in a deal valued at $4.4 billion. According to the announcement: Catalyst shareholders…
Biotech is a sector which is often mixed with a hodge-podge of winners and losers based on news flow from analysts and/or key drug developments which often have very little to do with the broad…
VIVUS Inc. (NASDAQ: VVUS) was trying to recover this morning and briefly spent some time in positive territory after an obvious concern for shareholders that the FDA is not quite as ready on an…
ViroPharma Incorporated (NASDAQ: VPHM) is getting crushed on news that the Food & Drug Administration has denied the petition filed by ViroPharma on March 17, 2006 related to the FDA’s proposed in vitro method…
VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some caution for its weight…
Who is right about what health care costs will be in the U.S. over the next decade? No one. The figure is too hard to come by, as is any number based on complex…
Biotech firm Galena Biopharma Inc. (NASDAQ: GALE) this morning priced a secondary offering of 8.5 million shares at $1.50/share, a discount of nearly 20% to last night’s closing price of $1.87. The company is…
Spectrum Phamaceuticals Inc. (NASDAQ: SPPI) has agreed to acquire rival drug firm Allos Therapeutics Inc. (NASDAQ: ALTH) for $1.82 in cash and one Contingent Value Right (CVR), in a deal worth about $206 million,…